“Effectiveness and Safety of Anlotinib with or without S-1 in the Treatment of Patients with Advanced Hepatocellular Carcinoma in Chinese Population: A Prospective, Phase 2 Study” (2023) Radiology and Oncology, 57(3), pp. 405–410. Available at: https://radioloncol.com/index.php/ro/article/view/4122 (Accessed: 23 September 2026).